Introduction
Myocardial excitation-contraction coupling begins with membrane depolarization, a process that activates voltagesensitive Ca 2q channels in the sarcolemma and allows a small amount of Ca 2q to enter the cell. This Ca 2q serves as a trigger to activate Ca 2q -release channels in the adja-Ž . w x cent junctional sarcoplasmic reticulum SR 1 : the ensuing efflux of stored SR Ca 2q increases the cytosolic free 2q
Žw 2q x . Ca ion concentration Ca and initiates contraction. Myocardial relaxation occurs when Ca 2q is removed from the cytosol, and re-uptake by the SR is quantitatively the most important mechanism for decreasing cytosolic w 2q x Ca . This is accomplished through the activity of the i SR Ca 2q pump protein, SERCA2, a Ca 2q -activated ATPase that pumps Ca 2q into the SR lumen. Re-uptake occurs in the non-junctional SR, primarily in the SR membrane and Ca 2q ATPase rich portion of the cell near w x the transverse tubules, at the Z-line of the sarcomere 3 .
Activity of the cardiac SR Ca pump is tonically inhibw x ited by an endogenous SR component, phospholamban 4 . , that is the junctional regions closely associated with the t-tubules and the nonjunctional 'corbular' SR.
SR function in heart failure
Aspects of myocardial contraction and relaxation associated with Ca 2q uptake and release by the SR are altered w x in the failing heart 7 . More than a century ago, Traube noted that patients with severe congestive heart failure tend to have alternating strong and weak pulses, or pulsus w x alternans 8 . This now widely recognized hallmark of congestive heart failure is caused by an alternation of weak and strong myocardial contractions termed mechanical al- Moreover, as will be described below, there is disagreement on the status of SERCA2 in failing hearts.
SERCA2 and SR Ca
2H uptake in failing hearts w x w x In most 21-30 but not all 31 studies of failing ventricular muscle, SERCA2 mRNA has been depressed. The situation with respect to the amount of SERCA2 protein is less clear, however. There have been reports of w x decreased SERCA2 in some failing rat 21,24,25 and w x w x human 18,32-34 hearts, but not in others 27-29,35 . Finally, in a study where both mRNA and protein were measured, the fractional decline in SERCA2 mRNA was w x more than double the decline in SERCA2 protein 36 .
With regard to SERCA2 function, SR Ca 2q uptake can w x w x be depressed 21,29,34,37,38 or unaltered 39,40 in hypertrophied andror failing myocardium. It should be noted, however, that few studies have assessed the status of phospholamban phosphorylation in these preparations. Differences in the degree of phospholamban phosphorylation between normal and failing hearts could strongly influence the results, and phospholamban phosphorylation has been shown to occur in vitro in the absence of w x b-adrenergic agonists 41 .
The SR Ca 2H release channel, or ryanodine receptor, in failing hearts
The SR Ca 2q release channel, often referred to as the Ž . ryanodine receptor RyR because of its affinity for the plant alkaloid, ryanodine, is a homotetramer composed of w x 564 kDa subunits 42 . This large protein forms the 'foot structures' seen in electron micrographs of cardiac dyads w x 43 . There are indications that RyR function may be altered in heart failure, but the extent to which this is due to altered gene expression is unclear. In myocytes from failing hypertensive SHHFrMcc-fa c p rats, however, the distribution of ryanodine receptors is unchanged relative to Ž . that seen in normal rat cells Fig. 1 , despite the clear alterations of excitation-contraction coupling previously w x observed in this model 11,58 .
A decreased density of RyRs has been observed in a rat w x model of pressure overload hypertrophy 44 , but failing human hearts have contained normal levels of RyR protein w x 18,32,33 . The data regarding mRNA levels in failing human hearts are somewhat contradictory, and seem to depend on etiology. In dilated cardiomyopathy, both dew x w x creases 45 and no change 46 in mRNA levels have been observed. In ischemic cardiomyopathy, there are decreased w x levels of mRNA 45,46 , but again, there are no changes in w x RyR protein levels 32 .
Calsequestrin in failing hearts
The calsequestrin content of the heart does not seem to w x be altered in heart failure. Studies of both mRNA 30,47 w x and protein 18,32,33,35 have shown no differences between failing and non-failing human hearts. For this reason, the relative amounts of other SR proteins are often normalized to calsequestrin, especially when there are concerns about variable amounts of non-myocyte protein in various tissue samples. Interestingly, although calsequestrin content is unchanged in most failing hearts, transgenic mice overexpressing cardiac calsequestrin ; 18-fold have pronounced cardiac hypertrophy and congestive heart failure accompanied by abnormalities in Ca 2q -induced 2q w x Ca release from the SR 48 .
Phospholamban in failing hearts
Phospholamban mRNA levels have been unchanged in w x failing rat hearts 26 and decreased in human heart failure w x 27-30,49 . Phospholamban protein levels have been found w x to be decreased in some studies of human failure 18,33 w x and unchanged in others 27-29,35,50 . A decrease in phospholamban could be viewed as a compensatory change that would relieve inhibition of SERCA2 in failing hearts, Ž . Ž . Fig. 1 . Ryanodine receptor distribution in control top and failing bottom rat heart cells. Age-matched Sprague-Dawley rats 18 months old normal heart c p w x Ž cells are compared with SHHFrMcc-fa rat heart cells in overt clinical heart failure 58 . Cells were fixed and permeabilized using 100% ethanol 15 min . Ž. Ž. Ž. at y208C , rinsed with 5% normal goat serum NGS and 3% bovine serum albumin BSA in phosphate buffered saline PBS and incubated with Ž . monoclonal primary antibodies 1:50 dilution overnight on a rocking platform at 58C against RyR. Cells were then rinsed 4 times with NGSrBSA in PBS, Ž . Ž . after which secondary antibodies were added 1:200 for 2 h at room temperature. Goat anti-mouse IgG GAM conjugated to fluorescene was used to label monoclonal primary antibodies. Cells were viewed using laser scanning confocal microscopy. Confocal microscopy was carried out on cells using a Zeiss 410 system microscope using excitation light of 488 nm and measuring emissions at 515-565 nm. The enlargement inset in each image clearly shows the distribution of the RyR which has been shown to be enriched along the z-lines of the SR. , in which case the frequency of spark production increased substantially. This occasionally allowed adjacent simultaneous sparks to coalesce and trigger waves of SR Ca 2q release w x and myofibrillar shortening 56 .
Local control and excitation-contraction uncoupling in heart failure
In response to membrane depolarization, the frequency of spark production increases as a function of sarcolemmal Ca 2q current, and summation of the Ca 2q sparks gives rise 2q w x to a typical whole cell Ca transient 55,57 . In hypertrophied and failing myocytes, the relation between trigger Ca 2q and spark frequency is altered such that more L-type Ca 2q current is needed to produce a given number of 2q w x Ca sparks 58 . That is, there is a degree of excitationcontraction uncoupling in heart failure.
Frequency-dependent phenomena in failing hearts
Another assumption about cardiac excitation-contraction coupling had been that frequency-dependent changes in contractile force reflect, in part, the time needed for Ca 2q taken up by the longitudinal SR to travel to the junctional and corbular sites of Ca 2q release. By extension, the altered frequency-dependent behavior of failing hearts was attributed to impaired SR Ca 2q uptake and an even slower filling of the SR release sites. However, studies of SR Ca 2q content using electron probe microw x w 2q x 19 w x analysis 59 and of free Ca using F y NMR 60 have shown that SR refilling is too rapid to explain attenuated extrasystolic beats or alternans. It has also been shown with caffeine pulses and rapid cooling contractures that the SR releases only a fraction of its available Ca 2q w x with each beat 61 . This led to the concept that the RyRs enter a refractory period after Ca 2q release. However, studies of individual SR Ca 2q release channels incorporated into planar lipid bilayers have failed to detect a true refractory state. Instead, there is a process termed adaptation, where sensitivity to a given level of activator Ca 2q declines as a function of time but where a further increase w 2q x in Ca can trigger an increase in the probability of w x channel opening 62-64 . It may be that RyRs in vivo can exhibit both adaptation and a refractory state.
Is the SR a central player or a bystander in heart failure?
Altered Ca 2q uptake and release by the SR accounts for many of the abnormalities in excitation-contraction coupling seen in the failing myocardium. However, these abnormalities probably do not arise primarily from an altered amount of individual SR proteins. As shown in this review, SERCA2, phospholamban, and the RyR can be present in normal amounts in hearts with end stage failure. In some instances, SR Ca 2q uptake can also be normal. The alternative explanation for altered SR function in heart failure is that the interaction between the L-type Ca 2q channels of the sarcolemma and the Ca 2q release channels of the SR is altered, possibly through a subtle Ž change in the spatial organization of the dyad see Gomeź . et al., this issue . Regulation of the gating of the RyRs may also differ in the failing myocyte. For example, isoproterenol is able to normalize the relation between L-type Ca 2q channel current and spark production in cells from rats with compensatory hypertrophy, but not in those from w x hearts with end stage failure 58 . More research is needed to characterize, in detail, the regulation of SR Ca 2q release in the normal and failing heart. In summary, the SR is clearly a central player and not a bystander in heart failure. However, changes in SR function are highly complex and do not necessarily involve changes in the amount of various SR components. 
